{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:51:05Z","timestamp":1770418265516,"version":"3.49.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Richard N. and Marilyn K. Witham Professorships"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ophtha.2020.03.014","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:52:13Z","timestamp":1584492733000},"page":"1270-1273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Intralesional Rituximab Injection for Low-Grade Conjunctival Lymphoma Management"],"prefix":"10.1016","volume":"127","author":[{"given":"Hakan","family":"Demirci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cem","family":"Ozgonul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7317-232X","authenticated-orcid":false,"given":"Ana Beatriz","family":"Diniz Grisolia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor M.","family":"Elner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2020.03.014_bib1","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1001\/jamaophthalmol.2015.6122","article-title":"Conjunctival lymphoma \u2013 an international multicenter retrospective study","volume":"134","author":"Kirkegaard","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2020.03.014_bib2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.oftal.2016.11.004","article-title":"Intralesional rituximab in primary conjunctival follicular lymphoma relapsed","volume":"92","author":"Rodr\u00edguez Villa","year":"2017","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.ophtha.2020.03.014_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ophtha.2010.04.036","article-title":"Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas","volume":"118","author":"Ferreri","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2020.03.014_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40662-019-0146-1","article-title":"Classification, diagnosis, and management of conjunctival lymphoma","volume":"6","author":"Tanenbaum","year":"2019","journal-title":"Eye Vis"},{"key":"10.1016\/j.ophtha.2020.03.014_bib5","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3109\/02713683.2014.959605","article-title":"Systemic rituximab immunotherapy in the management of primary ocular adnexal lymphoma: single institution experience","volume":"40","author":"Tuncer","year":"2015","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ophtha.2020.03.014_bib6","doi-asserted-by":"crossref","first-page":"895105","DOI":"10.1155\/2015\/895105","article-title":"Rituximab as single agent in primary MALT lymphoma of the ocular adnexa","volume":"2015","author":"Annibali","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ophtha.2020.03.014_bib7","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.ophtha.2003.09.049","article-title":"Long-term follow-up results of observation or radiation for conjunctival malignant lymphoma","volume":"111","author":"Matsuo","year":"2004","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642020302724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642020302724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:09:08Z","timestamp":1758982148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642020302724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":7,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0161642020302724"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2020.03.014","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intralesional Rituximab Injection for Low-Grade Conjunctival Lymphoma Management","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2020.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}